Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Other Non-Current Assets (2017 - 2025)

Historic Other Non-Current Assets for MedWellAI (MWAI) over the last 12 years, with Q3 2025 value amounting to $308231.0.

  • MedWellAI's Other Non-Current Assets fell 8158.72% to $308231.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $308231.0, marking a year-over-year decrease of 8158.72%. This contributed to the annual value of $386727.0 for FY2025, which is 7121.4% down from last year.
  • According to the latest figures from Q3 2025, MedWellAI's Other Non-Current Assets is $308231.0, which was down 8158.72% from $386727.0 recorded in Q2 2025.
  • In the past 5 years, MedWellAI's Other Non-Current Assets ranged from a high of $1.7 million in Q3 2024 and a low of $700.0 during Q1 2021
  • Moreover, its 5-year median value for Other Non-Current Assets was $578147.0 (2023), whereas its average is $540646.5.
  • As far as peak fluctuations go, MedWellAI's Other Non-Current Assets skyrocketed by 8259242.86% in 2022, and later tumbled by 8158.72% in 2025.
  • MedWellAI's Other Non-Current Assets (Quarter) stood at $700.0 in 2021, then surged by 82592.43% to $578847.0 in 2022, then fell by 0.12% to $578147.0 in 2023, then soared by 125.16% to $1.3 million in 2024, then plummeted by 76.32% to $308231.0 in 2025.
  • Its Other Non-Current Assets stands at $308231.0 for Q3 2025, versus $386727.0 for Q2 2025 and $1.1 million for Q1 2025.